Trinity Biotech (TRIB) Interest & Investment Income (2009 - 2024)
Trinity Biotech (TRIB) posted quarterly Interest & Investment Income of -$2.6 million for Q4 2024, down 302.34% year-on-year from $1.3 million in Q1 2024, and down 404.13% on a QoQ basis from $848000.0 in Q3 2024.
Trinity Biotech (TRIB) Interest & Investment Income (2009 - 2024) Analysis & Trends
Trinity Biotech (TRIB) has reported Interest & Investment Income for 16 consecutive years, with -$2.6 million the latest figure, recorded in Q4 2024.
- Quarterly Interest & Investment Income fell 302.34% year-over-year to -$2.6 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$1.7 million (down 82.77% YoY) and the FY2024 annual result came in at -$9.7 million, down 408.1% from the prior year.
- Interest & Investment Income eased to -$2.6 million in Q4 2024 per TRIB's latest filing, from $848000.0 in the prior quarter.
- Over the last five years, Interest & Investment Income for TRIB reached as high as $1.0 million in Q2 2021 and fell as low as -$7.0 million in Q4 2020.
- A 5-year average of -$628526.3 and a median of $2000.0 in 2020 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2020 — Interest & Investment Income sank 8085.23% — and 2021, when it surged 50800.0%.
- Year by year, Interest & Investment Income stood at -$7.0 million in 2020, then jumped by 72.89% to -$1.9 million in 2021, then surged by 65.2% to -$663000.0 in 2022, then rose by 3.32% to -$641000.0 in 2023, then sank by 302.34% to -$2.6 million in 2024.
- According to Business Quant data, Interest & Investment Income over the past three periods registered -$2.6 million, $848000.0, and $55000.0 for Q4 2024, Q3 2024, and Q1 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 40.98 Mn |
| 10 | Trinity Biotech | 111.52 Mn | 106.38 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -2.58 Mn |
| Sep 30, 2024 | 848,000.00 |
| Mar 31, 2024 | 55,000.00 |
| Dec 31, 2023 | -641,000.00 |
| Sep 30, 2023 | -492,000.00 |
| Jun 30, 2023 | 62,000.00 |
| Mar 31, 2023 | 154,000.00 |
| Dec 31, 2022 | -663,000.00 |
| Sep 30, 2022 | -1.00 Mn |
| Jun 30, 2022 | -218,000.00 |
| Mar 31, 2022 | 218,000.00 |
| Dec 31, 2021 | -1.91 Mn |
| Sep 30, 2021 | 194,000.00 |
| Jun 30, 2021 | 1.02 Mn |
| Mar 31, 2021 | 1,000.00 |
| Dec 31, 2020 | -7.03 Mn |
| Sep 30, 2020 | 3,000.00 |
| Jun 30, 2020 | 2,000.00 |
| Mar 31, 2020 | 31,000.00 |
| Dec 31, 2019 | 88,000.00 |